Achieve Life Sciences enters cooperation agreement with Dialectic Capital; appoints three new directors

ACHIEVE LIFE SCIENCES, INC.

Company to appoint three Designees to Board by March 21, 2023, filling vacancies from incumbent departures or board expansion.
Board size to be set at eight directors by 2023 Annual Meeting; incumbent directors may resign to comply.
Dialectic agrees to standstill, voting commitments, and non-disparagement until Expiration Date (generally 15 business days before 2024 annual meeting).
Designees to be nominated for election at 2023 Annual Meeting; at least one Designee on each committee except CMC.
Agreement terminates if Dialectic ownership falls below 10% or material breach.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.